Credit where due, Ultratech (NASDAQ:UTEK)
has finally been rewarding some investor patience. Almost anybody who
bought in the last two years is in the black now and three-year holders
should start feeling a little more encouraged. Orders are following the
upward trend across the industry and there is at least a plausible
chance that Ultratech can recapture some of the momentum it lost in
sub-28nm nodes as the industry starts moving to 10nm, 7nm and 5nm.
It's
also worth noting that despite management's objections, there has been a
change in the board of directors. Hopefully this will be a change for
the better, but this remains a brutally cyclical business and extremely
competitive. At this point, Ultratech doesn't seem undervalued, but
owning a fairly-valued highly cyclical company enjoying a cyclical
recovery in business isn't the worst thing in the world, as outperform
could push estimates, sentiment, and multiples higher in the coming
quarters.
Read more here:
Ultratech Grinding Out Progress
No comments:
Post a Comment